Shankara Buildpr

Which are the latest news on Shankara Buildpr?

Why is Shankara Buildpro Ltd falling/rising?

As of 05-Sep, Shankara Buildpro Ltd's stock price is rising to 1,297.10, driven by strong financial health, significant growth in sales and profits, and positive technical indicators. Despite a decline in investor participation, the stock's upward trend is supported by high institutional confidence and consistent performance.

As of 05-Sep, Shankara Buildpro Ltd's stock price is rising, currently at 1,297.10, reflecting a change of 13.05 (1.02%) upwards. This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 0.85% today and has shown a consecutive gain over the last two days, with a total return of 2.57% during this period. Additionally, Shankara Buildpro is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement.<BR><BR>Moreover, the company has demonstrated strong financial health, being net-debt free and showcasing high management efficiency with a return on equity (ROE) of 23.7%. The latest financial results indicate significant growth, with net sales increasing by 24.22% and profit after tax (PAT) rising by 25.64% over the last six months. These positive financial indicators, combined with high institutional holdings at 22.94%, suggest that informed investors have confidence in the company's fundamentals, further supporting the stock's rise. <BR><BR>However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 65.85% compared to the 5-day average. Despite this, the overall positive financial performance and recent gains in stock price contribute to the current upward trend of Shankara Buildpro Ltd.

What does Shankara Buildpr do?

Shankara Buildpro Ltd is a small-cap retail company specializing in building materials, with recent net sales of ₹1,890 Cr and a net profit of ₹36 Cr as of June 2026. Key metrics include a P/E ratio of 23.00 and a market cap of ₹3,007 Cr.

Overview: <BR>Shankara Buildpro Ltd operates in the retailing industry and is categorized as a small-cap company.<BR><BR>History: <BR>The incorporation year is not specified, and there are no status changes mentioned. The latest quarter for which sales and profit are reported is June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1,890 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 36 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 3,007 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 23.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.40% <BR>Debt-Equity: -0.01 <BR>Return on Equity: 23.74% <BR>Price-to-Book: 5.52 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Shankara Buildpr?

Shankara Buildpr's peers include A B Lifestyle, Medplus Health, Entero Healthcare, Aditya Vision, Khemani Distrib., M K Exim India, Novelix Pharma, Purple United, Magson Retail, and Silgo Retail. Notable peers exhibit varying management risks, growth rates, and capital structures, with Novelix Pharma showing the highest 1-year return at 98.36%.

Peers: The peers of Shankara Buildpr are A B Lifestyle, Medplus Health, Entero Healthcar, Aditya Vision, Khemani Distrib., M K Exim India, Novelix Pharma, Purple United, Magson Retail, and Silgo Retail.<BR><BR>Quality Snapshot: Excellent management risk is observed at Entero Healthcar, Aditya Vision, M K Exim India, and Purple United, while Average management risk is found at A B Lifestyle, Khemani Distrib., and the rest. Below Average management risk is noted at Medplus Health, Novelix Pharma, Magson Retail, and Silgo Retail. For growth, Excellent growth is seen at Medplus Health, Entero Healthcar, and Purple United, while Good growth is reported at Aditya Vision and Novelix Pharma, and the rest show Below Average growth. In terms of Capital Structure, Excellent capital structure is noted at M K Exim India, Good at Entero Healthcar and Khemani Distrib., Average at Aditya Vision and Purple United, and Below Average at A B Lifestyle, Medplus Health, Magson Retail, Silgo Retail, and Novelix Pharma.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Novelix Pharma at 98.36%, while the lowest is A B Lifestyle at -35.71%. Shankara Buildpr's 1-year return is not available for comparison. Additionally, Khemani Distrib., Magson Retail, and Silgo Retail have negative six-month returns.

How big is Shankara Buildpr?

As of 31st August, Shankara Buildpro Ltd has a market capitalization of 3,007.00 Cr, with recent net sales of 7,147.36 Cr and a net profit of 131.28 Cr.

As of 31st August, Shankara Buildpro Ltd has a market capitalization of 3,007.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Shankara Buildpro reported Net Sales of 7,147.36 Cr and a Net Profit of 131.28 Cr.<BR><BR>The latest reporting period for the balance sheet is March 2026, with Shareholder's Funds amounting to 545.64 Cr and Total Assets valued at 1,599.07 Cr.

Should I buy, sell or hold Shankara Buildpro Ltd?

Are Shankara Buildpro Ltd latest results good or bad?

Shankara Buildpro Ltd's latest Q4 FY26 results are strong, with a 65.77% increase in net profit and a 19.81% rise in revenue. However, the subsequent Q1 FY27 showed declines in both net profit and sales, raising concerns about future performance.

Shankara Buildpro Ltd's latest results for Q4 FY26 are quite strong, showcasing significant growth in both revenue and net profit. The company reported a net profit of ₹41.36 crore, which reflects a remarkable increase of 65.77% quarter-on-quarter and 41.69% year-on-year. Revenue also saw a substantial rise, reaching ₹1,996.30 crore, up 19.81% from the previous quarter and 27.95% year-on-year.<BR><BR>The operating margin improved to 3.49%, marking the highest level in seven quarters, while the PAT margin increased to 2.08%. This indicates that the company is effectively converting its revenue growth into profit, reflecting improved operational efficiency.<BR><BR>However, it's important to note that the subsequent quarter, Q1 FY27, has shown a decline in both net sales and net profit, with net profit dropping by 14.05% and sales decreasing by 5.34%. This suggests that while the latest results were strong, there may be some challenges ahead that could impact performance.<BR><BR>Overall, the latest results are considered good, but the recent decline in the following quarter raises some concerns about sustainability and future growth. Investors should keep an eye on how the company navigates these challenges moving forward.

Has Shankara Buildpro Ltd declared dividend?

Shankara Buildpro Ltd has declared a 50% dividend, with an ex-date of June 25, 2026. However, total returns over the past several years have been stagnant, showing no growth in price or dividends.

Shankara Buildpro Ltd has declared a 50% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 50%<BR>- Ex-date: 25 Jun 26<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 3-month period, the price return was 3.06%, the dividend return was 0.49%, resulting in a total return of 3.55%.<BR><BR>In the 6-month period, there was no price return or dividend return, leading to a total return of 0.0%.<BR><BR>For the 1-year period, both the price return and dividend return were 0%, resulting in a total return of 0.0%.<BR><BR>In the 2-year period, there was no price return or dividend return, leading to a total return of 0.0%.<BR><BR>During the 3-year period, the price return and dividend return were both 0%, resulting in a total return of 0.0%.<BR><BR>In the 4-year period, there was no price return or dividend return, leading to a total return of 0.0%.<BR><BR>For the 5-year period, both the price return and dividend return were 0%, resulting in a total return of 0.0%.<BR><BR>Overall, while Shankara Buildpro Ltd has declared a dividend, the total returns over the longer periods have been stagnant, indicating limited growth in both price and dividends in recent years.